Contact this trialFirst, we need to learn more about you.
Vaccine
FLUAD® Quadrivalent +2 More for Quality of Life
Recruiting3 awardsPhase 4
Durham, North Carolina
This trial will compare the safety of two different influenza vaccines given with the shingles vaccine. Approximately 400 older adults will be enrolled at two medical centers. Subjects will be randomized to receive either the aIIV4 or HD-IIV4 vaccines. All subjects will be assessed for 7 days post-injection and safety and tolerability compared between the two groups. Serious adverse events and adverse events of clinical interest will be assessed 42 days post-vaccination and compared between the two groups.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.